Christer Ahlberg, CEO of Cinclus Pharma, in interview with Nordnet
Cinclus Pharma's CEO Christer Ahlberg in an interview with Nordnet to talk about the company and the drug candidate linaprazan glurate ahead of the upcoming listing.
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Penserpodden
CEO of Cinclus Pharma, Christer Ahlberg, participated in Penserpodden to talk about the planned listing.
Read more
Presentation of the company and the development of linaprazan glurate from Redeye Transactions
Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Redeye Transactions June 13th.
Read more